FDA Inspection 1265449 — US Specialty Formulations LLC

US Specialty Formulations LLC — FEI 3010680515

The FDA completed an inspection of US Specialty Formulations LLC on Mar 26, 2025 in Allentown, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Allentown, PA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
122021 CFR 211.67(b)(3)Cleaning SOPs/instructions
136121 CFR 211.100(a)Absence of Written Procedures
360321 CFR 211.160(b)Scientifically sound laboratory controls
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.